HCA Healthcare (NYSE:HCA) Given a $416.00 Price Target by Barclays Analysts

HCA Healthcare (NYSE:HCA) received a $416.00 price objective from equities researchers at Barclays in a research report issued on Monday, MarketBeat reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s target price indicates a potential upside of 8.27% from the stock’s previous close.

Other equities analysts also recently issued reports about the stock. Guggenheim assumed coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating for the company. Wells Fargo & Company upgraded shares of HCA Healthcare from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Baird R W lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a report on Monday, April 28th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $388.80.

HCA Healthcare Price Performance

NYSE HCA traded up $2.73 during trading on Monday, reaching $384.23. The company’s stock had a trading volume of 202,887 shares, compared to its average volume of 1,617,586. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare has a one year low of $289.98 and a one year high of $417.14. The stock has a market capitalization of $92.44 billion, a PE ratio of 17.49, a P/E/G ratio of 1.10 and a beta of 1.46. The firm has a fifty day moving average of $354.51 and a 200 day moving average of $331.38.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion during the quarter, compared to analysts’ expectations of $18.26 billion. During the same quarter in the prior year, the company earned $5.36 EPS. The firm’s revenue was up 5.7% on a year-over-year basis. Analysts expect that HCA Healthcare will post 24.98 EPS for the current fiscal year.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares of the company’s stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

Several large investors have recently added to or reduced their stakes in HCA. Norges Bank purchased a new stake in shares of HCA Healthcare in the 4th quarter worth $840,286,000. GAMMA Investing LLC boosted its stake in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares in the last quarter. Nuveen LLC purchased a new stake in HCA Healthcare during the first quarter worth $569,217,000. Pacer Advisors Inc. increased its holdings in shares of HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after acquiring an additional 1,329,618 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after buying an additional 1,091,416 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.